2016 Webinars
Which Pharma Companies Are Ready For Precision Medicine in 2017: Benchmarking, Financial Risks and Predictions
Structural Mass Spectrometry for Drug Development
Applications of Flow Cytometry in the Drug Development Process
Improved Methods for Host Cell Protein Analysis
Novel CNS Biomarker Applications Enabled by Simoa Technology: Tau in Pre-Clinical & Clinical Studies
Genome-Wide cfDNA Analysis: Has the Time Come?
Leveraging New and Established Preclinical Oncology Models for Translational Success
Neurohistology in Research and Preclinical Drug Development – How Tissue Analysis Can Enhance Experimental Endpoints
Synergizing Transient and Stable Protein Expression for Accelerated Biotherapeutic Development
Global Commercialization of Companion Diagnostics: Biomarker Strategies to Improve Market Access
Methods, Metrics, and Effective Meetings: Best Practices in Portfolio Management
New Approaches for Mab Discovery against GPCRs, Ion Channels, and Transporters
Kinase Profiling and other Screening Solutions that span the Drug Discovery Process
Immunological Methods – Understanding and Enhancement of Pre-Clinical Animals Models of Disease
Blood Biomarkers for CNS Disorders
Cancer Stem Cell Models Empower the Discovery of Novel Therapeutic Targets using Advanced in Vivo Screening
Biotherapeutics Form and Function: Case Studies in Light Scattering
How Can Analytics Help Avoid the PD-L1 Chaos: 10 Years of Insights
Utilizing Gnotobiotic Mice to Understand the Role of the Microbiome in Murine Disease Models
High Content Analysis for Cell-based Target and Drug Discovery
The Impact of Preanalytical Variables in Blood: Enabling High Quality Protein Analysis
Overcoming the Pain Points of Next Generation Sequencing-Based Clinical Diagnostic Testing
Comparative Evaluation of the Simple Plex Immunoassay with other Multiplexing Technologies in a Biological Context
Molecular Snapshot with Driver-Map Targeted Expression Profiling Assay
Eurofins Pre-Clinical Cardiac Safety Screening for Proarrythmia
Personalized Medicine Ex-Oncology – What Are The Up And Coming Key Therapeutic Areas?
Matrix Interference in Ligand-Binding Assays: Modern Solutions to an Established Analytical Problem
Genomic approaches to model the immune landscape of human tumors for cancer immunotherapy
SPR Biosensors in Drug Discovery Research: Biophysical Applications from Industry
Meet Our UNcle: the All-In-One Biologics Stability Platform
Precision Medicine in Cancer Supportive Care
MFI as a Stability Indication Method
Assessment of Biosimilarity: Analytical Strategies to Satisfy Regulatory Requirements
Optimizing Protein Biotherapeutic Formulations with the Light Scattering Toolkit
The Role of Pharmacogenetic Testing in Personalized Medicine, and Challenges Associated with Clinical Implementation
Creative Project Management Methods for Resourcing Projects in Small versus Large Organizations
Nail Down Your Best Formulations Using Thermal Stability Screening
Novel Lipid Supplement, Cell Ess, Increases Antibody Production in CHO Cells for Industrial Manufacturing Applications
Protein Counting in Single Cancer Cells
Patient Derived Xenograft Program for Clinical Advancement
Global Laboratory Landscape Data and Strategy for Targeted Therapy Launches – Understanding CDx Intelligence and Trends
Genomic Approaches for the Advancement of Neo-Antigen Understanding in Immunotherapy
Humanizing Early Drug Discovery and Preclinical Safety Testing with Physiological iPS Cell Models